Literature DB >> 2134734

Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients.

M R Wallace1, D A Marchuk, L B Andersen, R Letcher, H M Odeh, A M Saulino, J W Fountain, A Brereton, J Nicholson, A L Mitchell.   

Abstract

Von Recklinghausen neurofibromatosis (NF1) is a common autosomal dominant disorder characterized by abnormalities in multiple tissues derived from the neural crest. No reliable cellular phenotypic marker has been identified, which has hampered direct efforts to identify the gene. The chromosome location of the NF1 gene has been previously mapped genetically to 17q11.2, and data from two NF1 patients with balanced translocations in this region have further narrowed the candidate interval. The use of chromosome jumping and yeast artificial chromosome technology has now led to the identification of a large (approximately 13 kilobases) ubiquitously expressed transcript (denoted NF1LT) from this region that is definitely interrupted by one and most likely by both translocations. Previously identified candidate genes, which failed to show abnormalities in NF1 patients, are apparently located within introns of NF1LT, on the antisense strand. A new mutation patient with NF1 has been identified with a de novo 0.5-kilobase insertion in the NF1LT gene. These observations, together with the high spontaneous mutation rate of NF1 (which is consistent with a large locus), suggest that NF1LT represents the elusive NF1 gene.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2134734     DOI: 10.1126/science.2134734

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  365 in total

1.  Fine mapping of quantitative trait loci using linkage disequilibria with closely linked marker loci.

Authors:  T H Meuwissen; M E Goddard
Journal:  Genetics       Date:  2000-05       Impact factor: 4.562

2.  Solution-based scanning for single-base alterations using a double-stranded DNA binding dye and fluorescence-melting profiles.

Authors:  K S Elenitoba-Johnson; S D Bohling
Journal:  Am J Pathol       Date:  2001-09       Impact factor: 4.307

Review 3.  Molecular mechanisms promoting the pathogenesis of Schwann cell neoplasms.

Authors:  Steven L Carroll
Journal:  Acta Neuropathol       Date:  2011-12-11       Impact factor: 17.088

4.  Construction of a yeast artificial chromosome library of tomato and identification of cloned segments linked to two disease resistance loci.

Authors:  G B Martin; M W Ganal; S D Tanksley
Journal:  Mol Gen Genet       Date:  1992-05

5.  Absence of linkage of Noonan syndrome to the neurofibromatosis type 1 locus.

Authors:  M Sharland; R Taylor; M A Patton; S Jeffery
Journal:  J Med Genet       Date:  1992-03       Impact factor: 6.318

6.  Differential expression of two fibroblast growth factor-receptor genes is associated with malignant progression in human astrocytomas.

Authors:  F Yamaguchi; H Saya; J M Bruner; R S Morrison
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-18       Impact factor: 11.205

7.  Identification of growth hormone receptor in localised neurofibromas of patients with neurofibromatosis type 1.

Authors:  K S G Cunha; E P Barboza; E C Da Fonseca
Journal:  J Clin Pathol       Date:  2003-10       Impact factor: 3.411

Review 8.  Mouse models of glioblastoma: lessons learned and questions to be answered.

Authors:  Loury Janbazian; Jason Karamchandani; Sunit Das
Journal:  J Neurooncol       Date:  2014-02-13       Impact factor: 4.130

9.  Minor disease features in neurofibromatosis type 1 (NF1) and their possible value in diagnosis of NF1 in children < or = 6 years and clinically suspected of having NF1. Neurofibromatosis team of Sophia Children's Hospital.

Authors:  M H Cnossen; K G Moons; M P Garssen; N M Pasmans; A de Goede-Bolder; M F Niermeijer; D E Grobbee
Journal:  J Med Genet       Date:  1998-08       Impact factor: 6.318

10.  Congenital anomalies and genetic disorders in families of children with central nervous system tumours.

Authors:  S M Jones; P C Phillips; P T Molloy; B J Lange; M N Needle; J A Biegel
Journal:  J Med Genet       Date:  1995-08       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.